Role of acetylcholine spasm provocation test as a pathophysiological assessment in nonobstructive coronary artery

Satoru Suzuki1, Koichi Kaikita2, Eiichiro Yamamoto1

  • 1Department of Cardiovascular Medicine and Center for Metabolic Regulation of Healthy Aging, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.

Insights

Coronary artery spasm is a key cause of nonobstructive coronary artery disease (CAD) and angina. The acetylcholine (ACh) provocation test aids in diagnosing coronary spasm, guiding treatment for patients with suspected CAD.

Area of Science:

  • Cardiology
  • Diagnostic Imaging
  • Vascular Medicine

Background:

  • Nonobstructive coronary artery disease (CAD) is increasingly recognized in patients presenting with angina or acute coronary syndrome (ACS).
  • Coronary artery spasm is a significant contributor to both stable angina and ACS in the absence of obstructive epicardial coronary stenosis.
  • Coronary spasm can lead to left ventricular dysfunction and heart failure, potentially responsive to calcium channel blockers.

Purpose of the Study:

  • To highlight the diagnostic utility of the acetylcholine (ACh) provocation test in identifying coronary artery spasm.
  • To emphasize the role of the ACh provocation test in managing patients with nonobstructive CAD.
  • To explore the ACh provocation test's applicability in assessing microvascular spasm and dysfunction.

Main Methods:

  • Invasive coronary angiography (CAG) with acetylcholine (ACh) provocation testing.
  • Assessment of coronary artery spasm during CAG.
  • Evaluation of microvascular function and spasm.

Main Results:

  • The ACh provocation test is effective in detecting coronary artery spasm, a common cause of nonobstructive CAD.
  • The test can identify high-risk patients with coronary spasm and concomitant organic coronary stenosis.
  • ACh provocation testing may also aid in assessing microvascular spasm or dysfunction.

Conclusions:

  • The acetylcholine (ACh) provocation test is a valuable tool for diagnosing coronary artery spasm in patients with nonobstructive coronary artery disease (CAD).
  • This invasive diagnostic modality can guide treatment strategies, including the use of calcium channel blockers, and identify high-risk individuals.
  • Increased utilization of the ACh provocation test by cardiologists is recommended for a comprehensive assessment of nonobstructive CAD pathophysiology.

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.7K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
114
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
285
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
235
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
114
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
438